GoodRx ran a 12-month survey to better understand the dynamics that shape prescription medication fills and consumer behavior, and found affordability, access issues, and drug shortages prevent many ...

Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill ...

Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...

As weight loss medications like Ozempic continue to gain popular, experts and patients are noticing varying effects of the drugs for people with eating disorders.

The FDA finally approved Novavax's Covid-19 vaccine, but placed restrictions on it that its two competitors in the U.S. do ...

Novo Nordisk is parting ways with its CEO Lars Fruergaard Jørgensen after the two parties mutually agreed that a change of ...

The success of Eli Lilly & Co. 's weight-loss and diabetes drugs has pushed the company's stock to new heights, helping the ...

IT feels like everyone is talking about – or taking – weight loss medications like Wegovy or Mounjaro. The jabs have ...

Dozens of Ozempic and Wegovy users have reported suffering from eye disorders they claim are associated with the drugs, including eight who have complained of blindness.

I never imagined that coming off a medication could feel like stepping off a cliff. But here I am, bracing for the freefall.

Indian market for these drugs has grown to nearly Rs 600 crore and is expected to keep growing. Weight-loss drugs are ...

Understanding the goals of your patients can help alleviate some pushback from the start of an appointment.